Nonsurgical Management and Pharmacologic Therapy for Post-traumatic Peripheral Trigeminal Neuropathic Pain Disorders - On Demand Access
-
You must log in to register
- Member - $50
- Resident Member - Free!
- Allied Staff Member - $50
- Professional Staff Nonmember - $100
- Other Nonmember - $100
The incidence of developing post-traumatic trigeminal neuropathy (PTTN) has been reported to range from 0.45% to 70% of injuries involving the inferior alveolar and lingual nerves. Based on ambispective clinical trials, no phenotypic presentation predicts outcome of microsurgery. In fact, microsurgery has only chance benefits. This 60-minute webinar will focus on the non-surgical management of PTTN. The pharmacologic therapies for acute and late-phase PTTN and their limitations, location-based treatments and alternative pain management strategies will be presented.
Learning Objectives
At the conclusion of this program, participants should be able to:
- Describe the different pharmacologic therapies, including evidence-based, for the proper dosages and regimens used to treat PTTN.
- Identify the differences between early- and delayed-phase protocols for the treatment of PTTN.
- Review alternative pain management strategies for the treatment of long-term PTTN..
An Internet-based CDE/CME Activity
Original Release Date: June 23, 2021
Expiration Date: June 23, 2024
Estimated time to complete this educational activity: 1.0 hours
Method of participation: Self-Study
Dr. John Zuniga, DDS, PhD, MS
Dr. Zuniga received his DDS from Tufts University School of Dental Medicine and completed a general dental residency and an oral and maxillofacial surgery residency at Strong Memorial Hospital at the University of Rochester. He also completed his MS and PhD in neuroscience at the University of Rochester School of Medicine and Dentistry. He is a professor in the Departments of Surgery and Neurology at the University of Texas Southwestern Medical Center.
Dr. Zuniga has authored more than 170 contributions to the scientific literature. His major research interests include regenerative neuroscience, acute and chronic orofacial pain as well as taste function. He has received numerous research grants, contracts and awards and served as a consultant to the editorial boards of a number of scientific and clinical journals and on the FDA advisory panel for dental products, the ABOMS Examination Committee and several research, resident education and faculty committees for AAOMS, the OMS Foundation and the ADA.
Relevant Conflict of Interest Disclosure: Consultant for Axogen, Inc.
Continuing Education Provider Approval
The American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education.
ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
The American Association of Oral and Maxillofacial Surgeons designates this activity for 1.0 continuing education credit(s).
AGD - Accepted Program Provider
FAGD/MAGD Credit
11/1/22-12/31/26
Provider ID# 214680
The American Association of Oral and Maxillofacial Surgeons (AAOMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Oral and Maxillofacial Surgeons designates this internet-based enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Key:
Complete
Next
Failed
Available
Locked